Explore the categories so you can find more about your search.

Categorie > Breast Cancer

Medipattern's B-CADTM Version 2 Shown To Increase Diagnostic Accuracy By 44% In Lesions Less Than 1 Cm In Size

Categorie : Breast Cancer
The Medipattern Corporation (TSX VENTURE:MKI), an award-winning developer of computer-aided detection (CAD) medical imaging software designed to aid physicians in making better informed biopsy decisions and to permit a higher standard of care for the millions of patients at risk of cancer, is ple ...

read more The Medipattern Corporation (TSX VENTURE:MKI), an award-winning developer of computer-aided detection (CAD) medical imaging software designed to aid physicians in making better informed biopsy decisions and to permit a higher standard of care for the millions of patients at risk of cancer, is ple read more Fri Feb 2008 Fri Feb 2008

Breast Cancer Biomarkers Uncovered

Categorie : Breast Cancer
Breast cancer sufferers should benefit from the first major piece of research by the University of Essex's Proteomics Unit.Led by Director Dr Metodi Metodiev, the unit has uncovered a panel of protein biomarkers which could lead to improved diagnosis of tumour types and fine-tuned treatment.'When we ...

read more Breast cancer sufferers should benefit from the first major piece of research by the University of Essex's Proteomics Unit.Led by Director Dr Metodi Metodiev, the unit has uncovered a panel of protein biomarkers which could lead to improved diagnosis of tumour types and fine-tuned treatment.'When we read more Fri Feb 2008 Fri Feb 2008

Anxiety Tied To DCIS Patients' Overestimation Of Cancer Risks

Categorie : Breast Cancer
Elevated levels of anxiety may cause women with ductal carcinoma in situ (DCIS), the most common form of non-invasive breast cancer, to overestimate their risk of recurrence or dying from breast cancer, suggests a study led by researchers at Dana-Farber Cancer Institute in Boston. ...

read more Elevated levels of anxiety may cause women with ductal carcinoma in situ (DCIS), the most common form of non-invasive breast cancer, to overestimate their risk of recurrence or dying from breast cancer, suggests a study led by researchers at Dana-Farber Cancer Institute in Boston. read more Fri Feb 2008 Fri Feb 2008

Hair Stylists Promote Breast Cancer Prevention Messages To Clients

Categorie : Breast Cancer
Authors of a Brooklyn, N.Y., study say hair stylists might be a good resource for both healthy hair and information on breast cancer prevention. However, it is not clear if learning about breast health practices at the beauty shop has a significant effect on client's health behavior.Hair stylists "a ...

read more Authors of a Brooklyn, N.Y., study say hair stylists might be a good resource for both healthy hair and information on breast cancer prevention. However, it is not clear if learning about breast health practices at the beauty shop has a significant effect on client's health behavior.Hair stylists read more Fri Feb 2008 Fri Feb 2008

Benefits Of Medicare Paid Mammography Lag For Black Women

Categorie : Breast Cancer
When Medicare began paying for older women to undergo preventive mammograms in 1991, doctors expected breast cancer mortality rates to drop. Breast cancer deaths did decrease, but new research has unveiled a discrepancy: African American women as a group do not benefit as much as white women.Breast ...

read more When Medicare began paying for older women to undergo preventive mammograms in 1991, doctors expected breast cancer mortality rates to drop. Breast cancer deaths did decrease, but new research has unveiled a discrepancy: African American women as a group do not benefit as much as white women.Breast read more Fri Feb 2008 Fri Feb 2008

Single Reader With CAD More Efficient, Yields Fewer False Positives, And Possibly More Sensitive Than Double Reading Of Mammograms

Categorie : Breast Cancer
Single reading of screening mammograms with computer-aided detection (CAD) is more efficient than double reading and yields a higher sensitivity than the first reader in a double reading program, according to a study conducted by researchers at Charlotte Radiology in Charlotte, NC. In addition, the ...

read more Single reading of screening mammograms with computer-aided detection (CAD) is more efficient than double reading and yields a higher sensitivity than the first reader in a double reading program, according to a study conducted by researchers at Charlotte Radiology in Charlotte, NC. In addition, the read more Fri Feb 2008 Fri Feb 2008

Accelerated Community Oncology Research Network, Inc. (ACORN), Initiates A Phase 2b Metastatic Breast Cancer Trial In Cooperation With Bayer And Onyx

Categorie : Breast Cancer
Accelerated Community Oncology Research Network, Inc. (ACORN), announced the initiation of a Phase 2b clinical trial evaluating the efficacy of Nexavar(R) (sorafenib) tablets in combination with the anticancer drug gemcitabine (Gemzar(R)) in patients with metastatic breast cancer whose cancer has pr ...

read more Accelerated Community Oncology Research Network, Inc. (ACORN), announced the initiation of a Phase 2b clinical trial evaluating the efficacy of Nexavar(R) (sorafenib) tablets in combination with the anticancer drug gemcitabine (Gemzar(R)) in patients with metastatic breast cancer whose cancer has pr read more Fri Feb 2008 Fri Feb 2008

How Breast Cancer Cells Are Disrupted By DDT Metabolite

Categorie : Breast Cancer
Research has shown that the main metabolite of the insecticide DDT could be associated with aggressive breast cancer tumours, but there has been no explanation for this observation to date. Now a report published in the open access journal Breast Cancer Research shows how DDT could act to disrupt ho ...

read more Research has shown that the main metabolite of the insecticide DDT could be associated with aggressive breast cancer tumours, but there has been no explanation for this observation to date. Now a report published in the open access journal Breast Cancer Research shows how DDT could act to disrupt ho read more Fri Feb 2008 Fri Feb 2008

AVADO Study Of Avastin Plus Docetaxel Chemotherapy Showed Improved Progression-Free Survival In Patients With Advanced Breast Cancer

Categorie : Breast Cancer
Genentech, Inc. (NYSE:DNA) announced that AVADO, a Roche-sponsored Phase III, placebo-controlled study evaluating AvastinŽ (bevacizumab) in combination with docetaxel chemotherapy met its primary endpoint of prolonging progression-free survival (PFS) in patients who had not received prior chemothera ...

read more Genentech, Inc. (NYSE:DNA) announced that AVADO, a Roche-sponsored Phase III, placebo-controlled study evaluating AvastinŽ (bevacizumab) in combination with docetaxel chemotherapy met its primary endpoint of prolonging progression-free survival (PFS) in patients who had not received prior chemothera read more Fri Feb 2008 Fri Feb 2008

Second Phase III Study Of Avastin(R) (Bevacizumab) In 1st Line Metastatic Breast Cancer Meets Its Primary Endpoint

Categorie : Breast Cancer
Roche announced that a phase III study in metastatic breast cancer investigating Avastin (bevacizumab) in combination with docetaxel chemotherapy compared to docetaxel alone, met its primary endpoint of improving the time patients live without their disease advancing. The findings come from the fir ...

read more Roche announced that a phase III study in metastatic breast cancer investigating Avastin (bevacizumab) in combination with docetaxel chemotherapy compared to docetaxel alone, met its primary endpoint of improving the time patients live without their disease advancing. The findings come from the fir read more Fri Feb 2008 Fri Feb 2008

Second Phase III Study Of Avastin In 1st Line Metastatic Breast Cancer Meets Its Primary Endpoint

Categorie : Breast Cancer
Roche announced that a phase III study in metastatic breast cancer investigating Avastin (bevacizumab) in combination with docetaxel chemotherapy compared to docetaxel alone, met its primary endpoint of improving the time patients live without their disease advancing. The findings come from the f ...

read more Roche announced that a phase III study in metastatic breast cancer investigating Avastin (bevacizumab) in combination with docetaxel chemotherapy compared to docetaxel alone, met its primary endpoint of improving the time patients live without their disease advancing. The findings come from the f read more Fri Feb 2008 Fri Feb 2008

Breast Care Solutions By Siemens Offer A Comprehensive Product Spectrum For The Diagnosis And Therapy Of Breast Cancer

Categorie : Breast Cancer
Among women, breast cancer is the most common cause of cancer death. Each year nearly 180,000 women in the United States are diagnosed with breast cancer. More than 40,000 a year die from this disease*. These facts stress the importance of a quality-ensured early detection of breast cancer as well a ...

read more Among women, breast cancer is the most common cause of cancer death. Each year nearly 180,000 women in the United States are diagnosed with breast cancer. More than 40,000 a year die from this disease*. These facts stress the importance of a quality-ensured early detection of breast cancer as well a read more Fri Feb 2008 Fri Feb 2008

Breast Cancer Blood Test Introduced To The Middle East

Categorie : Breast Cancer
The most prevalent cancer among women, breast cancer affects approximately 1.2 million women worldwide. While millions of American women receive mammography screenings each year, many women in the Middle East avoid this important screening procedure, often because of strong underlying cultural bias. ...

read more The most prevalent cancer among women, breast cancer affects approximately 1.2 million women worldwide. While millions of American women receive mammography screenings each year, many women in the Middle East avoid this important screening procedure, often because of strong underlying cultural bias. read more Fri Feb 2008 Fri Feb 2008

Breast Cancer Incidence Rising In Asian Women At Younger Age: Sunitinib Shows Potential As Treatment For Metastatic Disease

Categorie : Breast Cancer
The incidence of breast cancer in parts of Asia is rising steeply and catching up with rates in the western world, Dr Louis Chow, Medical Director of the Comprehensive Centre for Breast Diseases, UNIMED Institute, Hong Kong told oncologists attending the recent 1st Asian Breast Cancer Conference in ...

read more The incidence of breast cancer in parts of Asia is rising steeply and catching up with rates in the western world, Dr Louis Chow, Medical Director of the Comprehensive Centre for Breast Diseases, UNIMED Institute, Hong Kong told oncologists attending the recent 1st Asian Breast Cancer Conference in read more Fri Feb 2008 Fri Feb 2008

Susan G. Komen For The Cure Recognizes Cleveland Breast Cancer Activist With Volunteer Award

Categorie : Breast Cancer
Patricia Terstenyak of the Northeast Ohio Affiliate received Susan G. Komen for the Cure's annual Outstanding New Volunteer Award at Komen's 2008 Affiliate Leadership Conference, Feb. 8-9, in Dallas. As the world's largest breast cancer organization, Komen for the Cure's promise is to save lives and ...

read more Patricia Terstenyak of the Northeast Ohio Affiliate received Susan G. Komen for the Cure's annual Outstanding New Volunteer Award at Komen's 2008 Affiliate Leadership Conference, Feb. 8-9, in Dallas. As the world's largest breast cancer organization, Komen for the Cure's promise is to save lives and read more Fri Feb 2008 Fri Feb 2008

Breast Cancer Risk Can Be Cut With Personalized Medicine

Categorie : Breast Cancer
The time has come for breast cancer risk assessment, counseling and genetic testing to move from cancer specialists to the realm of primary care, according to a presentation at the AAAS annual meeting, held this year in Boston. ...

read more The time has come for breast cancer risk assessment, counseling and genetic testing to move from cancer specialists to the realm of primary care, according to a presentation at the AAAS annual meeting, held this year in Boston. read more Fri Feb 2008 Fri Feb 2008

Tamoxifen, Drug Discovery And The Future Of Selective Hormone Receptor Modulators

Categorie : Breast Cancer
How did a failed contraceptive become the first targeted therapy for the treatment of breast cancer? The transformation of tamoxifen, from cast-off to lifesaver, laid the foundation for a new class of therapeutics - selective estrogen receptor modulators - that could treat or prevent a variety of hu ...

read more How did a failed contraceptive become the first targeted therapy for the treatment of breast cancer? The transformation of tamoxifen, from cast-off to lifesaver, laid the foundation for a new class of therapeutics - selective estrogen receptor modulators - that could treat or prevent a variety of hu read more Fri Feb 2008 Fri Feb 2008

Research Points To Forkhead Protein's Importance In Many Types Of Cancer

Categorie : Breast Cancer
Two previously unconnected cancer-promoting proteins team up to ambush a critical tumor suppressor by evicting it from the cell's nucleus and then marking it for death by a protein-shredding mechanism, a team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in Nature ...

read more Two previously unconnected cancer-promoting proteins team up to ambush a critical tumor suppressor by evicting it from the cell's nucleus and then marking it for death by a protein-shredding mechanism, a team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in Nature read more Fri Feb 2008 Fri Feb 2008

Genentech's Avastin Effective At Treating Breast Cancer, Study Says

Categorie : Breast Cancer
FDA will decide on Feb. 23 whether to approve Genentech's colon and lung cancer treatment Avastin for treatment of metastatic breast cancer, the ...

read more FDA will decide on Feb. 23 whether to approve Genentech's colon and lung cancer treatment Avastin for treatment of metastatic breast cancer, the read more Fri Feb 2008 Fri Feb 2008

The Race Is On: Pharmaceutical Companies Compete To Develop Less Toxic More Efficacious Therapies To Combat Breast Cancer

Categorie : Breast Cancer
The Pharmaceutical / Biotechnology Group at Frost & Sullivan is pleased to announce its 2008 Quarterly Analyst Briefing Presentation on the targeted therapies segment of U.S. breast cancer therapeutics market to be held on Tuesday, February 26, 2008 at 12:00 p.m. CST / 1:00 p.m. EST. Physicians trea ...

read more The Pharmaceutical / Biotechnology Group at Frost & Sullivan is pleased to announce its 2008 Quarterly Analyst Briefing Presentation on the targeted therapies segment of U.S. breast cancer therapeutics market to be held on Tuesday, February 26, 2008 at 12:00 p.m. CST / 1:00 p.m. EST. Physicians trea read more Fri Feb 2008 Fri Feb 2008

<<< previous | 4 | 5 | 6 | 7 | 8 | 9 | 10 next >>>



     


Custom Search